Anticancer agent 83
Anticancer agent 83 is a potent anticancer agent, inhibits LOX IMVI cells growth with a GI50 value of 0.15 mM. Anticancer agent 83 reduces mitochondrial membrane potential and induces DNA damage to induces leukemia cells apoptosis.
For research use only. We do not sell to patients.
- CAS No.: 904815-29-8
- Formula: C20H19N5OS
- Molecular Weight:377.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human A549 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human A549 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| BALB/3T3 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against mouse BALB/3T3 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against mouse BALB/3T3 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| HaCaT | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human HaCaT cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human HaCaT cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| HCT-116 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| HCT-116 | GI50 |
8.4 μM
Compound: 4a
|
Antiproliferative activity against p53-deficient human HCT-116 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against p53-deficient human HCT-116 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| HEK293 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human HEK293 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human HEK293 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| HeLa | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human HeLa cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human HeLa cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| HL-60(TB) | GI50 |
2.8 μM
Compound: 4a
|
Antiproliferative activity against human HL-60(TB) cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human HL-60(TB) cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| HOP-92 | GI50 |
2.85 μM
Compound: 4a
|
Antiproliferative activity against human HOP-92 cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human HOP-92 cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| Jurkat | GI50 |
0.69 μM
Compound: 4a
|
Antiproliferative activity against human Jurkat cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human Jurkat cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| K562 | GI50 |
5.4 μM
Compound: 4a
|
Antiproliferative activity against human K562 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human K562 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| KB 3-1 | GI50 |
7.4 μM
Compound: 4a
|
Antiproliferative activity against human KB 3-1 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human KB 3-1 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| LOX IMVI | GI50 |
0.15 μM
Compound: 4a
|
Antiproliferative activity against human LOX IMVI cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human LOX IMVI cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| MCF7 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human MCF7 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human MCF7 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| MDA-MB-231 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| NCI-H460 | IC50 |
28 nM
Compound: 4a
|
Antiproliferative activity against human NCI-H460 cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human NCI-H460 cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| NCI-H522 | GI50 |
1.97 μM
Compound: 4a
|
Antiproliferative activity against human NCI-H522 cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human NCI-H522 cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| RXF 393 | GI50 |
4.27 μM
Compound: 4a
|
Antiproliferative activity against human RXF 393 cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human RXF 393 cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| SF-295 | GI50 |
2.71 μM
Compound: 4a
|
Antiproliferative activity against human SF-295 cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human SF-295 cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| SK-OV-3 | GI50 |
10 μM
Compound: 4a
|
Antiproliferative activity against human SK-OV-3 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human SK-OV-3 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| SR | GI50 |
1.77 μM
Compound: 4a
|
Antiproliferative activity against human SR cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human SR cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| THP-1 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human THP-1 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human THP-1 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
| TK-10 | GI50 |
3.21 μM
Compound: 4a
|
Antiproliferative activity against human TK-10 cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human TK-10 cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| UO-31 | GI50 |
2.88 μM
Compound: 4a
|
Antiproliferative activity against human UO-31 cells incubated for 48 hrs and measured by SRB assay
Antiproliferative activity against human UO-31 cells incubated for 48 hrs and measured by SRB assay
|
[PMID: 35973342] |
| WM793 | GI50 |
>100 μM
Compound: 4a
|
Antiproliferative activity against human WM793 cells incubated for 72 hrs and measured by MTT assay
Antiproliferative activity against human WM793 cells incubated for 72 hrs and measured by MTT assay
|
[PMID: 35973342] |
In Vitro
Anticancer agent 83 (compound 4a) (0.01-100 μM; 24 h) showing strong activity towards human colon carcinoma HCT116 p53−/− cells with deletion of P53 gene (GI50=8.4 μM), human epidermoid cervix carcinoma KB3-1 (GI50=7.4 μM), human ovarian carcinoma Skov 3 cells (GI50=10 μM), and human chronic myelogenous leukemia K562 cells (GI50=5.4 μM)[1].
Anticancer agent 83 (0.5 μM; 24 h) interrupts DNA stability and induction of apoptosis in Jurkat cells, and decreases mitochondrial membrane potential[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Human colon carcinoma HCT116 p53−/− cells with deletion of P53 gene, human epidermoid cervix carcinoma KB3-1, human ovarian carcinoma Skov 3 cells, and human chronic myelogenous leukemia K562 cells
-
Concentration:0.01, 0.1, 1, 10, 100 μM
-
Incubation Time:24 hours
-
Result:Inhibited cell viability in different cells with GI50s of 8.4 M (HCT116 p53−/−), 7.4 M (KB3-1), 10 M (Skov 3), and 5.4 M (K562), respectively.
-
Cell Line:Jurkat cells
-
Concentration:0.5 μM
-
Incubation Time:24 hours
-
Result:Induced morphological changes (including apoptotic bodies, membrane blebbing, chromatin condensation), and DNA fragmentation in Jurkat T-cells.
Chemical Information
-
CAS No. 904815-29-8
-
Molecular Weight 377.46
-
Formula C20H19N5OS
-
SMILES
O=C(C1=C(C)N(C2=CC=C(C(C)C)C=C2)N=N1)NC3=CC=C(SC#N)C=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)